Telemedical care of men with androgenetic alopecia demonstrates improved access to care and patient benefit

J Eur Acad Dermatol Venereol. 2022 Dec;36(12):e1018-e1020. doi: 10.1111/jdv.18426. Epub 2022 Jul 21.

Authors

F Abeck¹, J Kött¹, I Wiesenhütter^{2

3}, T Hiebenthal², I Hansen¹, S W Schneider¹, J von Büren²

Affiliations

¹ Department of Dermatology and Venereology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
² Wellster Healthtech Group, Munich, Germany.
³ Munich University Institute for Psychotherapy Training (MUNIP), Munich, Germany.

PMID: 35841293
DOI: 10.1111/jdv.18426

No abstract available

Publication types

Letter

MeSH terms

Alopecia* / therapy
Finasteride*
Health Services Accessibility
Humans
Male

Substances

Finasteride